$PBAM

Private Bancorp of America, Inc. Announces Strong Net Income for Third Quarter 2026

Private Bancorp of America, Inc. (PBAM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Private Bancorp of America, Inc. Announces Strong Net Income for Third Quarter 2026 Third Quarter 2026 Highlights • Net income for the third quarter of 2026 was $11.4 million, compared to $13.1 million in the prior quarter and $9.7 million in th

Original reporting
Published Oct 16, 2026, 12:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 12:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PBAM
Neutral
medium confidence
Mentioned
$PBAM
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PBAMNeutralMed
01

Why it matters

The earnings release confirms the bank’s profitability post‑uplisting and may influence its weighting in index reconstitutions.

02

Market read

First‑report earnings for a newly listed micro‑cap bank; modest impact expected.

03

What to watch

Potential upside from inclusion in the Russell 2000 and increased liquidity after the NASDAQ uplisting.

Relevance 7/10Novelty 7/10Timing: post‑market release

Background

Private Bancorp of America recently completed a NASDAQ uplisting, incurring $0.9 M in related expenses.

Company-level read

Ticker impact

$PBAMNeutralMedium confidence
Context

SEC Form 8‑K reports Private Bancorp of America’s unaudited Q3 2026 earnings, including net income of $11.4 M and EPS of $1.97.

Expected impact

neutral to slight upside as investors digest the earnings beat and NASDAQ uplisting benefits

Evidence & confidence

The numbers are new and primary, but the scale is small and the earnings change is modest, so any move is expected to be limited.

Market effects

Provides a data point for the regional community banking sector and recent NASDAQ uplistings.

Limited impact on U.S. small‑cap banking indices.

Minimal; primarily a U.S. micro‑cap event.

Counterpoint

The modest earnings beat may be outweighed by rising loan loss provisions and higher criticized loans, suggesting downside risk.

Key entities

  • Rick Sowers

    President and CEO of Private Bancorp of America, quoted on earnings.

  • Selwyn Isakow

    Chairman of the Board, commented on uplisting benefits.

Related articles

$BSVNMed

Piper Sandler raises Bank7 stock price target on strong growth

Piper Sandler raised its price target for Bank7 Corp. (BSVN) to $69.00, citing strong Q3 results with 2.24% return on assets and 16.4% return on tangible common equity. The stock is near its 52-week high, up 38% year-to-date. Piper Sandler also increased its EPS estimates for 2026 and 2027, anticipating growth from the Century Bank acquisition. Bank7 reported Q3 earnings of $1.06 per share, beating estimates, but missed on revenue.

$HOMBMed

Piper Sandler lowers Home Bancshares price target to $34 on growth

Piper Sandler cut its price target on Home Bancshares (HOMB) to $34 from $36, citing Q3 2026 results that beat EPS estimates but showed loan and deposit declines. The firm adjusted EPS estimates for 2026-2028, highlighting improved net interest margin and share repurchases. HOMB reported record Q3 earnings of $129.1M ($0.65 EPS), beating estimates, but revenue missed expectations. Analysts focus on strong profitability and capital levels.

$PRUMed

Keefe Bruyette cuts Prudential Financial stock price target on Japan sales impact

Keefe Bruyette & Woods cut Prudential Financial's (NYSE:PRU) price target to $119 from $123, citing lower earnings estimates due to Japan sales impact. Prudential reported mixed Q3 results, with alternative investment income beating estimates but PGIM revenues missing forecasts. The company also disclosed a negative $140M impact from POJ sales suspension. Other analysts, including Mizuho and Barclays, also lowered their price targets.